Min Zhu

4PUBLICATIONS
17CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 06, 2025
Pharmacokinetics of Odronextamab, A Bispecific T-Cell-Engaging Antibody, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.

Marçal Bravo Padros, Daniela J Conrado, Kamal Srinivasan

|Jun 05, 2025
CD20×CD3 Bispecific Antibodies in B-NHL: A Review of Translational Science, Pharmacokinetics, Pharmacodynamics, and Dose Strategy in Clinical Research.

|Dec 09, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer.

Min Zhu, Priyanka Madia, Alison Crawford

|Jan 16, 2019
Exposure-response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy.

Mita Kuchimanchi, Min Zhu, John D Clements

Pageof 1

Frequent Collaborators

3 joint publications

John D Davis

1 joint publications

Mita Kuchimanchi

1 joint publications

John D Clements

1 joint publications

Sameer Doshi